| Cisplatin |
ABCC6P1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AC006050.3 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AC015818.3 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AC022596.2 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AC022596.6 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AC090952.4.1 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
AFAP1-AS1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AK022798 |
Curated lncRNA |
gastric cancer |
|
| Cisplatin |
AK123263 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
AK125699 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
AK126698 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
AK293020 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
CES1P1 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
CUDR |
Curated lncRNA |
bladder cancer |
|
| Cisplatin |
ENSG00000088970.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000124835.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000132832.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000149656.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000153363.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000153363.8 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000163597.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000164621.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000167117.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000170161.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000170590.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000172250.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000174403.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000175611.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000175611.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000177406.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000177993.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000178193.5 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000178440.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000178947.8 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000178977.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000179219.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000179406.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000179743.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000180139.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000180279.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000180712.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000182109.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000182376.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000182648.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000183535.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000183674.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000184068.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000184068.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000185203.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000186019.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000186056.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000186615.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000186615.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000189223.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000196559.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000196756.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000196810.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000196951.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000197099.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000197332.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000197462.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000203279.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000203325.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000203386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000203497.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000203499.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000203706.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000203900.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000204044.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000204054.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000204055.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000204362.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000204685.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000204929.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000204934.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000204949.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000205056.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000205559.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000205663.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000205959.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000205959.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000206195.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000211683.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000211683.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000212694.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000212978.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000213468.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000213904.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000213904.4 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000213981.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000214049.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000214293.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000214353.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000214401.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000214719.7 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000214770.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000214773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000214837.4 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000215039.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000215190.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000215241.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000215256.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000215256.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000215304.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000215386.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000215386.6 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000215417.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000215483.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000220161.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000223379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000223390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000223396.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000223442.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000223442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000223522.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000223522.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000223587.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000223598.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000223635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000223653.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000223692.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000223704.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000223714.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000223725.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000223745.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000223759.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000223784.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000223804.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000223811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000223960.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000223969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000224050.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000224050.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000224079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000224079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000224218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000224276.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000224347.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000224597.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000224609.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000224614.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000224616.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000224623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000224623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000224635.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000224644.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000224652.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000224655.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000224660.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000224660.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000224745.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000224745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000224746.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000224804.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000224810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000224822.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000224842.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000224844.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000224959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225032.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000225037.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225037.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000225037.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000225039.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225057.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000225077.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000225092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000225096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000225113.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000225163.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000225177.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000225195.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000225213.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000225213.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000225235.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000225235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000225285.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000225298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000225313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000225329.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000225411.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000225442.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000225490.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000225493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000225511.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225578.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000225675.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000225744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000225760.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000225762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000225767.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000225767.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000225868.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000225872.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000225886.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000225891.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000225969.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000226009.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000226047.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000226067.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000226091.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000226091.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000226113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000226125.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000226179.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000226200.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000226237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000226291.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000226330.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000226352.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000226352.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000226390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000226419.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000226465.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000226643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000226645.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000226645.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000226690.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000226711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000226716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000226752.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000226752.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000226779.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000226824.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000226833.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000226842.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000226852.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000226852.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000226876.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000226876.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000226890.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000226900.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000226950.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000226969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000227066.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000227107.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000227145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000227155.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000227161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000227189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000227218.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000227258.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000227372.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000227407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000227431.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000227438.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000227495.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000227517.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000227527.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000227527.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000227527.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000227540.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000227543.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000227704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000227712.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000227773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000227811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000227811.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000227844.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000227848.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000227888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000227888.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000227953.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000227954.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000228033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000228043.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000228067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228137.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000228140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000228172.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000228172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000228172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000228192.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000228214.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000228221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000228223.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000228242.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000228274.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000228293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228302.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000228315.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000228327.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000228369.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000228386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000228485.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000228495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000228506.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000228512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228526.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000228544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000228544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000228614.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000228629.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228649.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000228677.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000228701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000228705.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000228737.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000228786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000228791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228798.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000228801.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000228817.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000228857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000228886.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000228917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228933.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000228989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000229043.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000229056.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000229109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229122.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000229124.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000229153.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000229167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229178.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000229178.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000229190.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000229195.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000229203.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000229203.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000229276.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000229325.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000229373.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000229380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229463.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000229521.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000229645.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000229656.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229692.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000229750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000229766.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000229780.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000229832.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000229832.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000229839.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000229839.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000229852.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000229896.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000229901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000229905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000229915.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000229950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000229956.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000229970.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000230010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000230010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000230021.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000230065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000230074.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000230084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000230091.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000230148.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000230285.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000230289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000230300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000230310.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000230368.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230415.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000230424.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000230487.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000230530.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000230536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000230561.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230613.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230641.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000230698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000230724.5 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230730.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000230732.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000230735.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230736.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000230736.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000230747.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000230747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000230844.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000230850.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000230852.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000230896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000230898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000230914.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000230978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231010.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000231102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000231113.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231305.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000231305.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000231324.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000231465.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000231486.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231486.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000231509.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000231512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000231527.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000231536.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000231607.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000231609.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000231611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000231616.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000231721.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231731.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000231764.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000231789.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000231795.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000231858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000231881.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000231892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000231927.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000231966.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000231969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000232019.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000232053.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000232065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000232118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000232118.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000232160.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000232160.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000232274.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000232311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000232336.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000232342.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000232363.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000232401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000232412.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000232470.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000232487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000232545.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000232545.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000232545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000232564.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000232586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000232618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000232623.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000232636.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000232640.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000232645.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000232656.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000232684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000232739.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000232754.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000232876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000232884.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000232907.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000232940.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000232973.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000233013.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000233013.4 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000233016.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000233030.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000233061.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000233067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000233108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233223.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000233242.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000233246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000233250.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000233359.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000233368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000233368.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000233368.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000233408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233411.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000233411.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000233452.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000233452.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000233509.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000233527.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000233547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233547.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000233602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000233611.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233672.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000233705.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000233791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000233799.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000233844.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000233860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000233862.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000233871.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000233901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000233930.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000233967.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000234019.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000234142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000234147.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000234177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000234197.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000234199.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000234222.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234232.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000234245.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000234286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000234327.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000234405.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000234428.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000234432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000234492.4 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234610.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234617.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000234665.4 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000234690.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000234722.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000234741.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000234753.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234772.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000234772.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000234773.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000234789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000234793.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000234817.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000234848.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000234880.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000234899.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000234915.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000234917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000234942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000234997.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000235033.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000235079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000235085.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000235106.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000235111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000235117.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000235123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000235192.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000235192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000235215.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000235246.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000235257.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000235280.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000235326.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000235381.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000235387.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000235397.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000235397.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000235448.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000235453.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000235481.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000235481.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000235522.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000235527.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000235527.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000235570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000235663.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000235702.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000235760.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000235772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000235795.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000235802.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000235806.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000235831.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000235834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000235881.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000235885.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000235890.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000235903.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000235903.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000235908.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000235927.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000235954.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000235999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000236003.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000236051.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000236069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000236098.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000236098.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000236115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000236140.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000236140.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000236144.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000236194.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000236200.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000236308.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000236310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000236324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000236337.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000236377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000236377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000236383.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000236384.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000236393.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000236438.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000236467.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000236514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000236535.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000236548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000236618.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000236778.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000236869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000236983.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000236986.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000237015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000237036.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000237037.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000237126.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000237133.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000237167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000237188.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000237200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000237357.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000237438.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000237453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000237461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000237461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000237476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000237489.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000237505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000237605.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000237613.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000237654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000237658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000237686.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000237686.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000237718.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000237738.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000237773.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000237790.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000237852.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000237862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000237877.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000237883.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000237934.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000237937.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000237938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000237943.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000237976.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000237993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000238009.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000238133.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000238140.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000238210.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000238279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000239002.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000239002.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000239219.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000239219.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000239353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000239377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000239415.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000239445.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000239462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000239467.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000239480.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000239498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000239569.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000239593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000239636.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000239636.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000239636.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000239664.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000239705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000239774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000239774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000239906.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000239911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000239911.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000240057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000240057.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000240211.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000240291.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000240476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000240499.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000240549.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000240571.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000240591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000240591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000240915.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000240915.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000240996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000240996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000240996.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000241014.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000241073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000241158.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000241211.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000241409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000241472.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000241684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000241860.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000241956.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000242021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000242125.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000242154.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000242282.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000242349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000242516.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000242553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000242798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000242973.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000243008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000243055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000243224.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000243389.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000243389.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000243433.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000243819.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000243819.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000243960.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000244041.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000244198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000244203.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000244300.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000244327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000244479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000244578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000244968.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000244998.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000245060.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000245148.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000245281.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000245311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000245466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000245498.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000245532.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000245598.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000245648.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000245748.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000245849.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000245904.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000246225.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000246250.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000246250.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000246250.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000246323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000246334.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000246451.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000246465.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000246523.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000246627.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000246731.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000246763.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000246774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000246889.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000246982.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000247131.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000247199.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000247213.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000247228.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000247240.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000247287.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000247287.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000247516.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000247556.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000247679.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000247679.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000247775.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000248027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000248138.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000248161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000248210.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000248256.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000248323.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000248356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000248388.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000248416.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000248476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000248508.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000248571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000248773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000248898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000248932.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000249096.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000249198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000249279.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000249348.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000249356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000249379.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000249417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000249532.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000249572.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000249641.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000249673.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000249685.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000249740.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000249740.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000249781.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000249885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000249899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000249996.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000250027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000250033.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000250039.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000250069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250069.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000250106.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000250116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000250133.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000250159.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000250192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000250303.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000250378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000250451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250616.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000250634.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000250708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250765.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000250770.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000250790.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250802.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000250820.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000250838.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000250893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000250903.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000250917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000250938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000250948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000250958.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000250986.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000250990.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000251003.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000251023.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000251034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000251059.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000251072.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000251143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000251151.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000251186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000251216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000251309.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000251330.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000251364.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000251370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000251379.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000251381.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000251497.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000251562.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000251580.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000251586.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000251600.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000251637.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000253111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000253197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000253307.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000253315.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000253344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000253347.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000253374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000253385.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000253392.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000253508.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000253535.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000253552.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000253553.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000253559.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000253567.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000253616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000253669.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000253708.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000253754.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000253764.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000253859.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000253875.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000253925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000253955.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000253955.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000253968.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000253972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000253978.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000254003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000254003.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000254028.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000254034.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000254034.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000254129.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000254142.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000254164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000254177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000254208.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000254231.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000254233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000254233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000254286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000254295.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000254298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000254315.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000254363.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000254389.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000254396.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000254397.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000254431.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000254432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000254432.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000254468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000254538.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000254539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000254542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000254662.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000254731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000254756.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000254762.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000254791.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000254791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000254812.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000254862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000254872.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000254973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000254985.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000254990.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000255020.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000255031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255145.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000255145.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255158.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255182.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000255234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000255241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000255248.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000255248.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255276.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255310.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000255320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000255322.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255326.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000255355.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255409.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000255443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000255455.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255456.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000255458.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255471.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000255474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000255507.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000255557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000255557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255670.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000255670.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000255670.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000255717.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000255723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000255741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000255811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000255931.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000255966.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000256101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000256124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000256150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000256196.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000256196.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000256360.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000256433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000256458.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000256473.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000256576.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000256588.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000256603.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000256609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000256633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000256742.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000256751.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000256802.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000256982.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000256984.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000257052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000257058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000257084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000257222.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000257329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000257345.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000257443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000257488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000257527.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000257534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000257551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000257557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000257568.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000257596.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000257621.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000257621.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000257647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000257671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000257696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000257698.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000257809.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000257817.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000257894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000257913.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000257947.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000257964.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000258017.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000258034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000258086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000258099.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000258203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000258260.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000258323.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000258325.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000258344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000258344.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000258441.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258443.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258520.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000258545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000258558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000258561.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000258646.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258646.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000258730.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000258736.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000258793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000258798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000258809.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000258809.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000258825.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000258858.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000258858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000258860.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000258914.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000258919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000258920.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000258940.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000258943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000258998.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000258999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000259048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259103.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259125.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000259126.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000259146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000259158.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000259181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259187.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000259206.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000259212.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259238.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259287.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000259306.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000259310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259349.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000259359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259376.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259396.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259424.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000259453.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000259475.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000259475.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000259475.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000259483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000259499.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000259504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000259553.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000259595.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259623.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000259654.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000259701.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259705.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259723.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000259736.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000259763.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000259767.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259771.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000259783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000259802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000259820.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000259826.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000259843.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000259876.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000259886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000259886.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259901.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000259915.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000259915.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000259994.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260005.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260011.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260037.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000260052.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260052.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260132.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260141.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260156.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260177.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000260193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000260198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000260213.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000260219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000260265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000260281.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000260296.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000260306.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260352.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000260366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000260367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260369.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260369.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260369.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000260388.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000260394.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000260396.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000260396.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000260404.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000260409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000260409.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260411.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260436.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260441.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000260469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000260536.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000260541.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260552.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000260558.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260579.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260597.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260630.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000260633.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260645.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000260657.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000260743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260743.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260743.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260744.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000260750.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000260790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260803.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260805.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000260807.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260814.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260814.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000260830.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000260841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260855.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000260877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000260891.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000260891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260907.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000260936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000260942.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000260948.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000260948.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000260949.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000260978.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000261002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000261008.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000261040.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000261049.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000261068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000261117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000261124.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261126.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000261170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261172.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000261183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000261187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261188.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261204.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000261220.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000261220.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261231.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000261242.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000261252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261266.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000261291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261326.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261337.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261338.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000261353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000261386.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000261404.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000261433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261433.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000261469.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000261469.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261474.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000261505.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261523.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000261533.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000261534.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000261542.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261582.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000261589.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261596.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000261632.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000261634.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261673.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000261697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261712.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261716.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261723.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000261770.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000261770.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261773.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000261780.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000261799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000261801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261804.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000261838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000261924.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000262223.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000262228.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000262298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000262312.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000262372.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262380.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000262380.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000262410.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000262434.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262482.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000262619.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000262652.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000262668.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262678.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262703.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000262714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000262772.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262837.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000262873.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000262920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000262921.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000262951.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000262966.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263004.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000263004.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000263050.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000263050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000263063.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263080.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000263164.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000263220.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263272.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263293.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000263300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000263327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000263338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000263345.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000263393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000263499.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000263627.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000263657.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000263657.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000263674.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000263709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000263731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000263745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000263847.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000263884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000263931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000264270.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000264365.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000264456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000264513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000264546.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000264577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000264672.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000264812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000264843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000264920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000265008.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000265142.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000265148.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000265185.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000265185.2 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000265206.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000265394.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000265479.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000265490.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000265511.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000265666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000265791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000265912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000266079.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000266236.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000266340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000266368.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000266411.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000266445.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000266456.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000266469.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000266498.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000266654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000266717.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000266783.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000266801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000266900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000266916.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000266923.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000266926.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000266930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000266941.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000266955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000266957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000266969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000266970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000266970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000266970.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000266970.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000266993.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000266993.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000266993.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000266999.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000266999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267040.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267053.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267065.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267067.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267121.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000267131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267141.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000267143.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267147.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267149.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000267150.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000267163.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267174.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000267175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000267199.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000267231.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267244.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267249.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267254.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000267255.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000267255.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267280.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000267282.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267296.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267316.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267322.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000267372.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000267390.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267397.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000267416.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267510.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000267543.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000267547.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000267549.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267560.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267568.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000267605.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000267638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267655.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000267665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267666.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000267667.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267702.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000267712.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267715.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000267729.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267745.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000267758.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267765.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000267767.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000267786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000267787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267798.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267834.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000267838.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000267868.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000267868.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000267890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000267898.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000267904.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000267919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000268015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000268015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000268061.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000268157.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000268201.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000268230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000268230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000268257.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000268262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000268266.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000268266.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000268340.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000268355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000268362.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000268364.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000268366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000268388.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000268392.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000268392.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000268458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000268471.3 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000268516.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000268544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000268564.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000268568.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000268605.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000268746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000268802.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000269019.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000269038.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000269051.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000269107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269148.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000269235.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000269293.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000269352.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269416.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269425.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000269427.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269481.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000269487.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000269535.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000269560.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269688.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000269696.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000269814.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000269834.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000269873.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000269887.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000269901.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000269918.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269924.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000269946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269947.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000269951.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000269958.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000269971.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000269974.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000269974.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000269978.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000269994.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000269996.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000270012.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000270012.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270018.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000270022.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000270030.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000270055.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270069.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270071.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000270074.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000270083.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270093.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270100.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000270102.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000270108.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000270115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000270117.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000270120.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000270127.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000270170.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000270177.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000270189.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000270302.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000270332.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000270457.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000270462.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000270589.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000270599.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000270607.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000270607.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000270673.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000270681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000270704.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000270720.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000270742.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000270828.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000270876.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000270949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000270964.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000270988.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000271109.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000271127.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000271151.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000271344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000271427.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000271533.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000271554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000271576.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000271579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000271659.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000271732.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000271743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000271743.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000271757.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000271762.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000271763.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000271766.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000271771.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000271778.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000271780.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000271788.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000271825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000271833.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000271833.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000271888.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000271894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000271912.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000271912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000271943.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000271963.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000271964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000271967.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000271967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000271983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000271992.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000271997.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272030.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272048.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272088.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000272102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000272102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000272102.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000272112.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000272123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272128.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000272192.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272205.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272216.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272217.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272217.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000272248.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000272301.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272328.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272334.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272335.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000272361.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000272370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000272373.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000272374.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000272438.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000272444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000272482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272518.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272524.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000272541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272551.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272556.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000272562.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000272567.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272604.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272610.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272622.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272657.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000272659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000272659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000272660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000272672.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000272677.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272682.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Cisplatin |
ENSG00000272682.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272707.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000272732.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272732.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272733.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000272777.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272787.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272788.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272789.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272828.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000272832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000272849.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000272859.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000272913.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000272915.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000272945.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000272950.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000272966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000272989.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000272993.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273000.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273004.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273011.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273015.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000273056.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273066.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000273066.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Cisplatin |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000273073.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273096.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000273125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Cisplatin |
ENSG00000273164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273175.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000273176.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000273179.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273181.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000273188.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273190.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273233.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273243.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
ENSG00000273245.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Cisplatin |
ENSG00000273249.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000273249.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000273257.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000273287.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000273290.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000273306.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000273321.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Cisplatin |
ENSG00000273325.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000273335.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273335.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Cisplatin |
ENSG00000273344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273373.1 |
Predicted lncRNA |
Sarcoma |
|
| Cisplatin |
ENSG00000273384.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Cisplatin |
ENSG00000273399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Cisplatin |
ENSG00000273416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000273416.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Cisplatin |
ENSG00000273416.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Cisplatin |
ENSG00000273443.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Cisplatin |
ENSG00000273449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000273481.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Cisplatin |
ENSG00000273486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Cisplatin |
FOXO3B |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
HBBP1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
HOTAIR |
Curated lncRNA |
lung adenocarcinoma |
|
| Cisplatin |
hsa-3149 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
hsa-let-7b-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-let-7c |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-1224-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-1225-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-1226-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-1228-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-1234-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-130a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-134 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-135a-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-139-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-142-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-150-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-153-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-181d |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-193a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-195-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-19a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-19b-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-20b-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-24-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-27a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-330-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-338-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-365a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-365b-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-371a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-483-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-497-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-572 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-575 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-622 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-623 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-629-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-630 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-638 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-650 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-663a |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-760 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-765 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-770-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-874 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-892b |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-92a-3p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-940 |
predicted miRNA |
NCI60 |
|
| Cisplatin |
hsa-miR-99b-5p |
predicted miRNA |
NCI60 |
|
| Cisplatin |
KRT16P1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
KRT16P2 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
KRT17P2 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
KRT42P |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
let-7a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
let-7a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
let-7b |
Curated miRNA |
glioblastoma |
|
| Cisplatin |
let-7b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7c |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
let-7c |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
let-7c |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7c |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
let-7d |
Curated miRNA |
oral cancer |
|
| Cisplatin |
let-7d |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7d |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
let-7e |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
let-7e |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7e |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
let-7f |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7f-1 |
Curated miRNA |
medulloblastoma |
|
| Cisplatin |
let-7g |
Curated miRNA |
esophageal carcinoma |
|
| Cisplatin |
let-7g |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
let-7g |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
let-7i |
Curated miRNA |
esophageal carcinoma |
|
| Cisplatin |
let-7i |
Curated miRNA |
ovarian and breast cancer |
|
| Cisplatin |
let-7i |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
LINC00210 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
LINC00520 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
LINC01277 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
LNC-AL353997.1-1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-GDE1-3 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-GSTM4 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-GTPBP1-2 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
lnc-IGL |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-KCNA3-3 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-LIMS3-2 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-M1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-MEX3B-4 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-MRPL33-1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-RP11-80A15.1.1-2 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-SLCO5A1-1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
lnc-ZNF205-1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
LOC283174 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
LOC728537 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
MEG3 |
Curated lncRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-010a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-016b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-019b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-020 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-023a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-023b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-026a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-029c |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-092 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-093 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-099 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-100 |
Curated miRNA |
chondrosarcoma |
|
| Cisplatin |
miR-100 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-100 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-100 |
Curated miRNA |
pancreatic cancer |
|
| Cisplatin |
miR-100 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-100* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-101 |
Curated miRNA |
bladder cancer |
|
| Cisplatin |
miR-101 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-101 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-101 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-101 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-103 |
Curated miRNA |
- |
|
| Cisplatin |
miR-106a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-106a |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-106a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-106b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-106b |
Curated miRNA |
testicular cancer |
|
| Cisplatin |
miR-107 |
Curated miRNA |
- |
|
| Cisplatin |
miR-107 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-107 |
Curated miRNA |
non small cell lung cancer |
|
| Cisplatin |
miR-10a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-10a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-10a |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-10a |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-10a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-10a |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-10a* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-10b |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-10b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-10b |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-10b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-10b* |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-122 |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-1224 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1228* |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-1229 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1238 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1246 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-1258 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-125a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-125a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-125a |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-125a |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Cisplatin |
miR-125b |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-125b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-125b |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Cisplatin |
miR-125b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-125b |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-126 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-126 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-127 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-127 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-1271 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1273d |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1275 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-128 |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-128 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-128 |
Curated miRNA |
prostate cancer |
|
| Cisplatin |
miR-128-2 |
Curated miRNA |
non-small-cell lung cancer |
|
| Cisplatin |
miR-129 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-129 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-129 |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-1290 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-1297 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-1299 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-1307 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-130a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-130a |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-130a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-130b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-130b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-132 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-132* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-1321 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-133a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-133a |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-133a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-133b |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-133b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-133b |
Curated miRNA |
ovarian carcinoma |
|
| Cisplatin |
miR-134 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-135a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-135a |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-135b |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-135b |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-135b* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-136 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-136 |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-136 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-136 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-137 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-138 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-138 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-139 |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-139 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-141 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-141 |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-141 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-141 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-141 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-142 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-143 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-144 |
Curated miRNA |
prostate cancer |
|
| Cisplatin |
miR-145 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-145 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-145 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-145 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-145 |
Curated miRNA |
glioblastoma |
|
| Cisplatin |
miR-145 |
Curated miRNA |
primary epithelial ovarian cancer |
|
| Cisplatin |
miR-146 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-146a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-146a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-146a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-146a |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-146a |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-146a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-146b |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-146b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-146b |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-147 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-1470 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-148a |
Curated miRNA |
adenocarcinoma |
|
| Cisplatin |
miR-148a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-148b |
Curated miRNA |
non-small cell cancer |
|
| Cisplatin |
miR-148b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-149 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-149* |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-15 |
Curated miRNA |
epidermoid carcinoma, |
|
| Cisplatin |
miR-150 |
Curated miRNA |
bladder cancer |
|
| Cisplatin |
miR-150 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-152 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-153 |
Curated miRNA |
colorectal cancer |
|
| Cisplatin |
miR-155 |
Curated miRNA |
caski cervical cancer |
|
| Cisplatin |
miR-155 |
Curated miRNA |
colon cancer |
|
| Cisplatin |
miR-155 |
Curated miRNA |
epidermoid carcinoma, |
|
| Cisplatin |
miR-155 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-155 |
Curated miRNA |
neuroblastoma |
|
| Cisplatin |
miR-155 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-155 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-155* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-15a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-15a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-15b |
Curated miRNA |
cervical cancer |
|
| Cisplatin |
miR-15b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-15b |
Curated miRNA |
tongue cancer |
|
| Cisplatin |
miR-16 |
Curated miRNA |
cervical cancer |
|
| Cisplatin |
miR-16 |
Curated miRNA |
epidermoid carcinoma, |
|
| Cisplatin |
miR-16 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-16 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-16 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-17 |
Curated miRNA |
non-small-cell lung cancer |
|
| Cisplatin |
miR-17 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-181a |
Curated miRNA |
adenocarcinoma |
|
| Cisplatin |
miR-181a |
Curated miRNA |
cervical squamous cell carcinoma |
|
| Cisplatin |
miR-181a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-181a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-181a |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-181a |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-181a |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-181a |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-181a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-181a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-181a |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-181a* |
Curated miRNA |
adenocarcinoma |
|
| Cisplatin |
miR-181a* |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-181a-2 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-181b |
Curated miRNA |
adenocarcinoma |
|
| Cisplatin |
miR-181b |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-181b |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-181b |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-181c* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-181d |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-181d |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-181d |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-181d |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-182 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-182 |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-182 |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-182 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-182 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-183 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-183 |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-183 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-183 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-183 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-185 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-185 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-185 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-185 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-186* |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-186* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-186* |
Curated miRNA |
lung carcinoma |
|
| Cisplatin |
miR-186* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-187 |
Curated miRNA |
peripheral T-cell lymphoma |
|
| Cisplatin |
miR-188 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-18a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-18a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-18b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-190 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1908 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-1908 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-191 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-1915 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-192 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-192 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-193a |
Curated miRNA |
bladder cancer |
|
| Cisplatin |
miR-193a |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-193a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-193a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-193a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-193b |
Curated miRNA |
cancer |
|
| Cisplatin |
miR-193b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-193b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-193b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-193b* |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-194 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-194 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-194 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-194 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-194 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-195 |
Curated miRNA |
epidermoid carcinoma, |
|
| Cisplatin |
miR-195 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-195* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-196 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-196a |
Curated miRNA |
non-small-cell lung cancer |
|
| Cisplatin |
miR-196a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-197 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-1973 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-198 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-198 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-199a |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-199a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-199b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-199b |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-19a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-19a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-19b |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-19b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-19b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-19b-1 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-1b-1 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-200a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-200a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-200a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-200b |
Curated miRNA |
- |
|
| Cisplatin |
miR-200b |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-200b |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-200b |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-200b |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-200b |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-200b |
Curated miRNA |
tongue cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
- |
|
| Cisplatin |
miR-200c |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
colorectal cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
endometrial carcinoma |
|
| Cisplatin |
miR-200c |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
melanoma |
|
| Cisplatin |
miR-200c |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-200c |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-202 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-203 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-203a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-203a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-204 |
Curated miRNA |
colorectal cancer |
|
| Cisplatin |
miR-204 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-204 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-205 |
Curated miRNA |
- |
|
| Cisplatin |
miR-205 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-205 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-205 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-205 |
Curated miRNA |
melanoma |
|
| Cisplatin |
miR-205 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-205 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-205 |
Curated miRNA |
prostate cancer |
|
| Cisplatin |
miR-206 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-206 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-20a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-20a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-20a |
Curated miRNA |
non-small-cell lung cancer |
|
| Cisplatin |
miR-20a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-20b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-20b |
Curated miRNA |
non-small-cell lung cancer |
|
| Cisplatin |
miR-20b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-20b |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-21 |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
head and neck squamous cell carcinoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
neuroblastoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
non-small-cell lung cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
oral squamous cell carcinoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-21 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-21 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-210 |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-210 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-214 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-214 |
Curated miRNA |
cervical cancer |
|
| Cisplatin |
miR-214 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-214 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-214 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-215 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-216 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-217 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-218 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-218 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-218 |
Curated miRNA |
cervical cancer |
|
| Cisplatin |
miR-218 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-218 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-22 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-22 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-22 |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-22 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-22 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-221 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-221 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-221 |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-221 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-221 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-222 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-222 |
Curated miRNA |
oral squamous cell carcinoma |
|
| Cisplatin |
miR-222 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-222 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-223 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-223 |
Curated miRNA |
colon cancer |
|
| Cisplatin |
miR-223 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-223 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-223 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-224 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-224 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-224 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-224 |
Curated miRNA |
ovarian papillary serous carcinoma |
|
| Cisplatin |
miR-224 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-23a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-23a |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-23a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-23a |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-23a |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-23b |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-24 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-24 |
Curated miRNA |
neuroblastoma |
|
| Cisplatin |
miR-25 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-25 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-25 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-25 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-25 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-25* |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-26a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-26a |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-26b |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-26b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-27a |
Curated miRNA |
bladder cancer |
|
| Cisplatin |
miR-27a |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-27a |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-27a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-27a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-27a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-27a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-27b |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-27b |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-27b |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-27b |
Curated miRNA |
kidney cancer |
|
| Cisplatin |
miR-27b |
Curated miRNA |
liver cancer |
|
| Cisplatin |
miR-27b |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-27b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-27b |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-29 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-296 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-296 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-296 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-296 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-296 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-296 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-297 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-29a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-29a |
Curated miRNA |
oral squamous cell carcinoma |
|
| Cisplatin |
miR-29a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-29a |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-29b |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-29b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-29b-1 |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-29c |
Curated miRNA |
nasopharyngeal carcinoma |
|
| Cisplatin |
miR-29c |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-300 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-300 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-302 |
Curated miRNA |
head and neck squamous cell carcinoma |
|
| Cisplatin |
miR-302a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-302a |
Curated miRNA |
testicular embryonal carcinoma |
|
| Cisplatin |
miR-302b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-302c |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-302d |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-30a |
Curated miRNA |
- |
|
| Cisplatin |
miR-30a |
Curated miRNA |
ovarian carcinoma |
|
| Cisplatin |
miR-30b |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-30b |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-30b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-30c |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-30c |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-30d |
Curated miRNA |
anaplastic thyroid carcinoma |
|
| Cisplatin |
miR-30d |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-30d |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-30e |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-31 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-31 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-31 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-31 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-31 |
Curated miRNA |
prostate cancer |
|
| Cisplatin |
miR-3131 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-3135a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-3149 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-3162 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-3175 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-3183 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-32 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-320 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-320a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-320a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-320a |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-320b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-320b |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-320c |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-320d |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-320e |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-321* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-326 |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-328 |
Curated miRNA |
colorectal cancer |
|
| Cisplatin |
miR-331 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-331 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-335 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-335 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-335* |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-338 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-339 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-339 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-33a |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-33a |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-33a* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-34 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-340 |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-342 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-342 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-345 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-34a |
Curated miRNA |
bladder cancer |
|
| Cisplatin |
miR-34a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-34a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-34a |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-34a |
Curated miRNA |
medulloblastoma |
|
| Cisplatin |
miR-34a |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-34a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-34c |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-34c |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-3607 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-362 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-362 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-3621 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-363 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-363 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-363 |
Curated miRNA |
hepatocellular carcinoma |
|
| Cisplatin |
miR-363 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-363* |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-365 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-365 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-3651 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-3653 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-3687 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-370 |
Curated miRNA |
endometrioid ovarian cancer |
|
| Cisplatin |
miR-370 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-371 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-372 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-373 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-373 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-373* |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-374a |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-374a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-374a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-374b |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-374b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-374c |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-375 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-375 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-375 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-376c |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-378 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-378b |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-378b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-378c |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-382 |
Curated miRNA |
osteosarcoma |
|
| Cisplatin |
miR-382 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-383 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-383 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-411 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-412 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-421 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-423 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-423 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-424 |
Curated miRNA |
epidermoid carcinoma, |
|
| Cisplatin |
miR-424 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-424* |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-4258 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-4284 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-4285 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-4289 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-429 |
Curated miRNA |
- |
|
| Cisplatin |
miR-429 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-429 |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-429 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-429 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-429 |
Curated miRNA |
primary epithelial ovarian cancer |
|
| Cisplatin |
miR-429 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-4297 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-4311 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-432 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-449a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-449c |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-450b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-451 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-451 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-452 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-452 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-455 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-455 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-455 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-4701 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-4728 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-4763 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-483 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-484 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-485 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-485 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-486 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-486 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-489 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-489 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-489 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-489 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-490 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-491 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-492 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-493* |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-494 |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-495 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-497 |
Curated miRNA |
colorectal cancer |
|
| Cisplatin |
miR-497 |
Curated miRNA |
epidermoid carcinoma, |
|
| Cisplatin |
miR-497 |
Curated miRNA |
gastric cancer and lung cancer |
|
| Cisplatin |
miR-497 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-498 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-501 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-502 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-503 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-503 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-503 |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-506 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-508 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-509 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-5096 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-512 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-513a |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-515 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-516b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-517* |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-517a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-517b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-517c |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-518a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518c |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518c* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-518c* |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-518c-AS |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-518d |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518e |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518e |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-518f |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-518f* |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-519a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-519a |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-519b |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-519b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-519c |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-519d |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-519e* |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-520a |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-520b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-520c |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-520d* |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-520e |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-520e |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-520f |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-520f |
Curated miRNA |
neuroblastoma |
|
| Cisplatin |
miR-520f |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-520g |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-520h |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-521 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-522 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-523 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-524 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-525 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-526 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-526b |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-532 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-532 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-541* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-542 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-545 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-551b |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-551b* |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-574 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-576 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-576 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-582 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-584 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-584 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-590 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-598 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-601 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-603 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-608 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-610 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-612 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-615 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-625 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-625 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-628 |
Curated miRNA |
tongue squamous cell carcinoma |
|
| Cisplatin |
miR-630 |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-630 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-631 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-634 |
Curated miRNA |
bladder cancer |
|
| Cisplatin |
miR-634 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-636 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-637 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-638 |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-638 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-638 |
Curated miRNA |
triple-negative breast cancer |
|
| Cisplatin |
miR-639 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-642 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-642 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-645 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-648 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-659 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-663 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-663 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-663a |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-675 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-7 |
Curated miRNA |
breast cancer |
|
| Cisplatin |
miR-7 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-7 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-7 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-708 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-744 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-744 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-760 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-766 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-801 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-873 |
Curated miRNA |
glioma |
|
| Cisplatin |
miR-875 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-876 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-877 |
Curated miRNA |
gastric cancer |
|
| Cisplatin |
miR-881* |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-885 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-886 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-886 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-886 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Cisplatin |
miR-886 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-9 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-9 |
Curated miRNA |
primary epithelial ovarian cancer |
|
| Cisplatin |
miR-920 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-923 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-923 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-923 |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-92a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-92a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-92a-1 |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-92a-2* |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-92b |
Curated miRNA |
esophageal adenocarcinoma |
|
| Cisplatin |
miR-92b |
Curated miRNA |
non-small cell lung cancer |
|
| Cisplatin |
miR-92b |
Curated miRNA |
small cell lung cancer |
|
| Cisplatin |
miR-92b |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-93 |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-93 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-93 |
Curated miRNA |
ovarian cancer stem cells |
|
| Cisplatin |
miR-93* |
Curated miRNA |
laryngeal cancer |
|
| Cisplatin |
miR-933 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-935 |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-940 |
Curated miRNA |
lung cancer |
|
| Cisplatin |
miR-942 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-944 |
Curated miRNA |
Bladder Carcinoma |
|
| Cisplatin |
miR-96 |
Curated miRNA |
cancer |
|
| Cisplatin |
miR-96 |
Curated miRNA |
ehrlich ascites tumor |
|
| Cisplatin |
miR-96 |
Curated miRNA |
esophageal cancer |
|
| Cisplatin |
miR-96 |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-96 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-98 |
Curated miRNA |
lung adenocarcinoma |
|
| Cisplatin |
miR-98 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-98 |
Curated miRNA |
squamous cell carcinoma |
|
| Cisplatin |
miR-99a |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-99a |
Curated miRNA |
germ cell tumor |
|
| Cisplatin |
miR-99a |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-99b |
Curated miRNA |
esophageal squamous cell carcinoma |
|
| Cisplatin |
miR-99b |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-99b* |
Curated miRNA |
hepatocellular cancer |
|
| Cisplatin |
miR-Plus B1114 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-Plus C1115 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-PlusA1087 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miR-PlusC1049 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miRPlus-A1015 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miRPlus-C1110 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miRplus-F1064 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miRPlus-F1147 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miRPlus-F1231 |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
miRPlus-G1246-3p |
Curated miRNA |
ovarian cancer |
|
| Cisplatin |
NAPSB |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
PSORS1C3 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
PVT1 |
Curated lncRNA |
gastric cancer |
|
| Cisplatin |
SRGAP3-AS2 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
TP53TG1 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
TTC39C-AS1 |
Curated lncRNA |
lung squamous cell carcinoma |
|
| Cisplatin |
uc003bgl.1 |
Curated lncRNA |
non-small-cell lung cancer |
|
| Cisplatin |
UCA1 |
Curated lncRNA |
bladder cancer |
|
| Cisplatin |
WDR86-AS1 |
Curated lncRNA |
lung squamous cell carcinoma |
|